HIGHLIGHTS
- who: Mingqiu Hu and colleagues from the Koblenz University of Applied Sciences, Germany have published the paper: Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis, in the Journal: (JOURNAL) of December/30,/2020
- how: Continuous data were compared using ANOVA and categorical data with Fisher`s exact test.
SUMMARY
Following an initial period during which patients respond well to ADT (median duration of 18-24 months), the levels of prostate-specific antigen (PSA) tend to rise along with disease . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.